(Q33955775)

30 July 2017

1 reference

title

Tryptophan and 5-hydroxytryptophan for depression (English)

1 reference

30 July 2017

K Shaw

1

1 reference

30 July 2017

J Turner

series ordinal

2

1 reference

30 July 2017

C Del Mar

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

30 July 2017

2002

0 references

published in

1 reference

30 July 2017

CD003198

1 reference

30 July 2017

3

1 reference

Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors.

30 July 2017

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Tryptophan dosage critical for its antidepressant effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Thyroid Function and the Response to Liothyronine in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Letter: Treatment of unpolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Evaluation of the combination of tryptophan and ECT in the treatment of depression. II. Biochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Evaluation of the combination of tryptophan and ECT in the treatment of depression. I. Clinical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Effect of L-Tryptophan on Brain Serotonin Metabolism in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Affective disorder: studies with amine precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Potentiation of a monoamine oxidase inhibitor by tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Kinetics of L-tryptophan in depressive patients: a possible correlation between the plasma concentrations of L-tryptophan and some psychiatric rating scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Neuroendocrine response to 5-hydroxytryptophan in seasonal affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Letter: Tryptophan/imipramine in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Addition of L-tryptophan to electroconvulsive treatment in endogenous depression. A double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Letter: Treatment of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Tranylcypromine in depression resistant to cyclic antidepressions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Comparison of the antidepressant action of tryptophan, tryptophan/5-hydroxytryptophan combination and nomifensine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Has tryptophan any anticonvulsive effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Plasma tryptophan to large neutral amino acid ratios in depressed and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Effects of sleep deprivation on serotonin function in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Lack of effect of tryptophan treatment in demented gerontopsychiatric patients. A double-blind, crossover-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Potentiation of the antidepressant action of clomipramine by tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Letter: Potentiation of antidepressant action of clomipramine by tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Controlled Studies of the Acute Antidepressant Effects of Lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Serotonin precursors as antidepressive agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Eosinophilia myalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

L-Tryptophan and 5-hydroxytryptophan in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

A clinical and biochemical study of a trial of iproniazid in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

Control of brain neurotransmitter synthesis by precursor availability and nutritional state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003198

10.1002/14651858.CD003198

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference